Our team always works with the goal of achieving and demonstrating the highest quality for our products. From polymer synthesis to polymer analysis everything from a single source..

Synthesis

Our expertise lies in controlled polymerization under inert conditions, with precise control of molecular weight and low dispersity..

Our area of expertise are various functionalization reactions for the production of polymers with precisely defined end groups.

We use modern purification techniques to achieve the exceptionally high purity of our products.

The synthesis and purification of 2-azoline monomers are also part of our area of expertise.

In summary, we produce on a small to medium scale:

• Monomers and polymers of high purity
• Polymers with a high degree of functionalization and a narrow molecular weight distribution at various degrees of polymerization

Analytics

We use self-developed, robust analytical methods (purity, content) for both our products and their starting materials.

Through our methods, we are able to chromatographically separate (HPLC) and quantify polymer impurities that differ only in a small functional unit at the chain end.

In addition, we analyze:

• the molecular weight and its distribution (SEC)
• the molecular structure (NMR, MALDI)
• the water content (Karl-Fischer-titration)
• Residual solvents and other inorganic impurities
• the appearance of substance solutions (according to EP)

Here, we primarily use standard methods that have been adapted to the requirements of polymers.

Quality

Since December 19, 2024, our quality management system has been certified according EN ISO 9001.

This means, among other things, that:

• we develop polyoxazolines with clearly defined specifications
• our manufacturing processes are controlled and reproducible thanks to the determination of critical parameters
• our analytical methods are validated based on risk
• we continuously develop and improve our processes

Here, we also consider the application of our products in the pharmaceutical industry and voluntarily incorporate GMP aspects that we have identified based on risk.